Skystar Bio-Pharmaceutical Reports 27% Growth in Revenue From Continuing Operations in First Quarter Fiscal Year 2010

XI’AN, CHINA–(Marketwire – 05/18/10) – Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI – News ) (“Skystar” or the “Company”) , a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today reported unaudited first quarter fiscal year 2010 earnings, for the period ended March 31, 2010. First Quarter 2009 Highlights Revenue increases 27 …

Read More